(A-B, E-H) BALB/c mice were injected i.p. with 106 control (RBC, black circles) or P. yoelii-infected (iRBC, white squares) erythrocytes. Splenocytes from groups of 4 mice were stained with antibodies to CD11c and CD45RB. (A) Two subpopulations, R1 (CD11chi) and R2 (CD11cloCD45RBhi) were gated for analysis by flow cytometry. The FACS plots are representative of splenocytes from day 0 and day 10 post-infection. (B) At the indicated days post-injection, splenocytes were analyzed for the two subsets, expressed as the proportion of CD11c+ cells (DCs). (C-D) C57BL/6 mice were injected i.p. with 106 P. berghei ANKA-infected erythrocytes (C). BALB/c mice were injected i.p. with 106 P. yoelii YM-infected erythrocytes (D). Splenocytes were harvested on the days indicated and stained as in (A). The values on the plots represent the proportion of the CD11c+ gate that each subset comprises. (E) On the days indicated post-injection, two subpopulations, CD11chi and CD11cloCD45RBhi were gated, and analyzed for their expression of mPDCA-1 (heavy line) by flow cytometry. A staining control was also analyzed (grey line). (F-G) At the indicated days post-injection, the number of total spleen cells (F) and the absolute number of each DC subset (G) were quantified. (H) Parasitaemia were quantified by Giemsa-stained slides. The results are representative of three independent experiments. Error bars represent standard deviation within groups of 4 mice (*, P < 0.05; ***, P < 0.001 when comparing iRBC to RBC by two-way ANOVA).